BACK TO TOP
KSE100
183,049.80
896.25
(0.49%)
KSE100PR
57,444.94
281.27
(0.49%)
ALLSHR
109,841.96
406.56
(0.37%)
KSE30
55,980.65
209.40
(0.38%)
KMI30
259,664.80
1734.22
(0.67%)
BKTI
52,787.22
64.20
(0.12%)
OGTI
36,172.75
-290.18
(-0.80%)
KMIALLSHR
70,650.70
189.19
(0.27%)
PSXDIV20
83,078.86
249.02
(0.30%)
UPP9
63,986.15
583.02
(0.92%)
NITPGI
47,617.58
196.54
(0.41%)
NBPPGI
51,765.64
169.21
(0.33%)
MZNPI
32,203.18
336.51
(1.06%)
JSMFI
47,510.66
-602.37
(-1.25%)
ACI
25,515.26
88.03
(0.35%)
JSGBKTI
76,092.76
96.38
(0.13%)
HBLTTI
18,006.09
10-02-2026
3.71
(0.02%)
MII30
23,580.58
177.58
(0.76%)
Macter International Limited
PHARMACEUTICALS
Rs.355.10
5.69
(1.63%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Wed, Feb 11, 2026 3:45 PM
REG
DFC
CSF
ODL
Open
347.77
High
362.00
Low
342.01
Volume
115,179
CIRCUIT BREAKER
314.47 — 384.35
DAY RANGE
342.01 — 362.00
52-WEEK RANGE ^
248.00 — 621.82
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
349.41
VAR
13.00
HAIRCUT
25.00
P/E Ratio (TTM) **
20.88
1-Year Change * ^
27.93%
YTD Change * ^
6.98%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Macter International Limited was incorporated in Pakistan in 1992 as a private limited company and was converted into a public limited company in 2011. The principal activity of the company is to manufacture and market pharmaceutical products.

KEY PEOPLE
Asif MisbahCEO
Amanullah KassimChairperson
Asif JavedCompany Secretary
ADDRESS

F-216, SITE, Karachi

WEBSITE

www.macter.com

REGISTRAR

F.D. Registrar Services (SMC-Pvt) Ltd 17th Floor, Saima Trade Tower-A I.I. Chundrigar Road, Karachi

AUDITOR

AF Ferguson Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
16,267,492.49
Shares
45,811,018
Free Float
16,033,856
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025Transmission of Quarterly Report for the Period Ended September 30, 2025 View   PDF
Oct 27, 2025Financial Results for the Quarter Ended September 30, 2025 View   PDF
Oct 3, 2025Transmission of Annual Report for the year ended June 30, 2025 View   PDF
Sep 23, 2025Financial Results for the Year Ended June 30, 2025 View   PDF
Apr 30, 2025Transmission of Quarterly Report for the Period Ended March 31, 2025 View   PDF
DateTitleDocument
Feb 6, 2026Board Meeting View   
Oct 27, 2025Adoption of Resolutions by the Members in Annual General Meeting View   PDF
Oct 27, 2025Adoption of Resolutions by the Members in Annual General Meeting
REVOKED
View   PDF
Oct 17, 2025Board Meeting View   
Oct 3, 2025Notice of Annual General Meeting View   PDF
DateTitleDocument
Jan 29, 2026Material Information View   PDF
Dec 22, 2025Material Information View   PDF
Dec 5, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Nov 7, 2025Corporate Briefing Session View   PDF
Nov 7, 2025Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales9,914,3187,535,3826,680,3915,311,248
Profit after Taxation737,534427,163392,868317,533
EPS16.109.328.587.19
Q1 2026Q3 2025Q2 2025Q1 2025
Sales2,768,9852,426,9522,754,9932,164,536
Profit after Taxation156,22094,913299,04692,960
EPS3.412.076.532.03
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)44.9642.2241.6844.70
Net Profit Margin (%)7.445.675.885.98
EPS Growth (%)72.758.6219.338.12
PEG0.431.170.592.14

Payouts

Financial Reports